Project Grant R01DK140210
- Federal Project Grant Award Summary The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) awarded a $805,464 Project Grant to the University of Washington (effective August 1, 2025 through April 30, 2030) under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847) to conduct research on the genetic and environmental contributions to obesity pathogenesis. The research addresses a critical gap in understanding how genetic and environmental...
- Federal Project Grant Award Summary The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) awarded The Washington University a $720,353 Project Grant on March 25, 2026, under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847). The award, which extends through January 31, 2031, funds basic biomedical research investigating neural circuits in the preoptic hypothalamus that regulate energy expenditure and metabolism. The research...
- Federal Project Grant Award Summary The University of Washington received a $799,756 Project Grant from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847), effective July 1, 2025, through June 30, 2030. This research initiative will conduct a randomized controlled trial (RCT) targeting childhood obesity intervention in 240 prepubertal girls at risk for accelerated pubertal...
- Federal Project Grant Award Summary The University of Washington received a $1.71 million Project Grant award dated September 25, 2025, from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847). This collaborative research initiative will develop artificial intelligence (AI)-designed mini-proteins, termed epibinders, to enhance the efficiency of pancreatic islet tissue...
- Federal Project Grant Award Summary The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) awarded The Washington University $233,250 on September 15, 2025, under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847) to conduct research on the role of protein phosphatase 1K (PPM1K) in macrophage activation and metabolic disease. The research project, which extends through August 31, 2027, investigates how branched chain amino acid (BCAA)...
- Federal Grant Award Summary The University of Washington received a $404,883 Project Grant award from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847), effective September 1, 2025, through August 31, 2027. This award supports the development of submicron-resolution integrated spatial transcriptomics and proteomics technologies for studying kidney disease. The project focuses...
- Federal Project Grant Award Summary The University of Washington received a $825,905 Project Grant award dated March 6, 2026, from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847). The grant supports the development of an immunocompetent three-dimensional colon chip—an advanced bioengineered ex vivo experimental platform designed to model Crohn's disease and investigate the...
- Federal Grant Award Summary The University of Washington received a $654,536 Project Grant award from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847), effective April 15, 2026, through January 31, 2031. The award funds basic biomedical research investigating the pathogenic mechanisms of neutrophil elastase (NE) mutations in hereditary neutropenia, specifically severe...
- Federal Project Grant Award Summary The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) awarded The Washington University a $709,931 Project Grant under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847) effective August 15, 2025, with a completion date of June 30, 2030. This award supports investigator-initiated basic biomedical research investigating neutrophil regulation of brown adipose tissue (BAT) homeostasis and its implications...
- Federal Grant Award Summary The University of Washington received a $164,188 Project Grant award from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847), effective September 15, 2025, through June 30, 2030. This award supports a five-year mentored research and career development program focused on investigating the role of intestinal chondroitin sulfate glycosaminoglycans in...
The University of Washington received a $888,773 Project Grant award from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847), effective April 15, 2026, with a completion date of January 31, 2031. This biomedical research project investigates the mechanistic contributions of hypothalamic microglia and perineuronal nets (PNNs)—specialized extracellular matrix structures—to obesity pathogenesis. The research examines how diet-induced obesity triggers inflammatory activation of microglia in the arcuate nucleus, a brain region critical for food intake and body weight regulation, and how this activation correlates with loss of PNNs that normally regulate neuron activity in energy homeostasis pathways. The primary deliverable under this award is foundational scientific research aimed at elucidating the interrelated mechanisms by which microglia activation and PNN loss contribute to obesity development while paradoxically improving glucose tolerance in high-fat diet conditions. The project employs experimental approaches including microglia ablation and silencing studies, analysis of neuropeptide signaling in arcuate nucleus neurons (particularly AGRP and POMC neurons), and investigation of PNN stability under varying inflammatory conditions. Expected outcomes include peer-reviewed publications, mechanistic insights into obesity etiology, and identification of potential therapeutic targets for intervention in diet-induced obesity and related metabolic disorders.Federal Project Grant Award Summary
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $888.8k | 4/8/26 |